CellBion to list shares on KOSDAQ market in October

CellBion Inc., a South Korean radiopharmaceuticals firm, plans to sell some 1.91 million new shares through an initial public offering on the secondary KOSDAQ market next month, the company’s CEO said Wednesday.

The target price range for the shares…

Read More »